{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-Toxoplasma gondii activity", "Arbutin", "Orostachys malacophylla", "Phenolic compounds", "Structure-activity relationship"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36195177", "DateCompleted": {"Year": "2022", "Month": "10", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1016/j.exppara.2022.108397", "S0014-4894(22)00191-6"], "Journal": {"ISSN": "1090-2449", "JournalIssue": {"Volume": "242", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Experimental parasitology", "ISOAbbreviation": "Exp Parasitol"}, "ArticleTitle": "Anti-Toxoplasma gondii agent isolated from Orostachys malacophylla (Pallas) Fischer.", "Pagination": {"StartPage": "108397", "MedlinePgn": "108397"}, "Abstract": {"AbstractText": ["Botanical medicinal plants have aroused our interest to deal with Toxoplasmosis which can causes serious public health problems. Nipagic acid, gallic acid, ethyl gallate, phloretic acid, protocatechuic acid, methyl p-coumarate, arbutin, and homoprotocatechuic acid are first isolated from Orostachys malacophylla (Pallas) Fischer, their inhibition rate, survival rate, biochemical and viscera index are evaluated using gastric epithelia strain-1(GES-1). Among them, arbutin can effectively prolong the survival time of mice acutely infected with T. gondii, and exhibit the same curative effect as Spiramycin (Spi) group in terms of the glutathione (GSH) and malondialdehyde (MDA) content, alleviate hepatomegaly and splenomegaly. Structure-activity relationship (SAR) and molecular docking implies that phenolic hydroxyl group would be preferred for improvement of activity. In a summary, arbutin is a potential anti-T. gondii candidate for clinical application."], "CopyrightInformation": "Copyright \u00a9 2022 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy of of College, Yanbian University, Yanji, 133002, Jilin Province, China."}], "LastName": "Piao", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy of of College, Yanbian University, Yanji, 133002, Jilin Province, China."}], "LastName": "Jin", "ForeName": "Lili", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy of of College, Yanbian University, Yanji, 133002, Jilin Province, China."}], "LastName": "Cheng", "ForeName": "Xu", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy of of College, Yanbian University, Yanji, 133002, Jilin Province, China."}], "LastName": "Yan", "ForeName": "Weifeng", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy of of College, Yanbian University, Yanji, 133002, Jilin Province, China."}], "LastName": "Zhang", "ForeName": "Changhao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Analysis and Inspection Center, Yanbian University, Yanji, 133002, Jilin Province, China. Electronic address: shwang@ybu.edu.cn."}], "LastName": "Wang", "ForeName": "Sihong", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy of of College, Yanbian University, Yanji, 133002, Jilin Province, China. Electronic address: cmjin@ybu.edu.cn."}], "LastName": "Jin", "ForeName": "Chunmei", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Exp Parasitol", "NlmUniqueID": "0370713", "ISSNLinking": "0014-4894"}, "ChemicalList": [{"RegistryNumber": "8025-81-8", "NameOfSubstance": "Spiramycin"}, {"RegistryNumber": "C5INA23HXF", "NameOfSubstance": "Arbutin"}, {"RegistryNumber": "102-32-9", "NameOfSubstance": "3,4-Dihydroxyphenylacetic Acid"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}, {"RegistryNumber": "632XD903SP", "NameOfSubstance": "Gallic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Toxoplasma"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Spiramycin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Arbutin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "3,4-Dihydroxyphenylacetic Acid"}, {"QualifierName": [], "DescriptorName": "Malondialdehyde"}, {"QualifierName": [], "DescriptorName": "Glutathione"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Gallic Acid"}], "CoiStatement": "Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests Sihong Wang reports financial support was provided by National Natural Science Foundation of China. Lili Jin reports financial support was provided by National Natural Science Foundation of China. Chunmei Jin reports financial support was provided by National Natural Science Foundation of China."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "5", "Day": "9"}, {"Year": "2022", "Month": "9", "Day": "17"}, {"Year": "2022", "Month": "9", "Day": "27"}, {"Year": "2022", "Month": "10", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "4", "Hour": "19", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36195177", "10.1016/j.exppara.2022.108397", "S0014-4894(22)00191-6"]}}], "PubmedBookArticle": []}